Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Preferred Shares: 2011

  • Adma Biologics' Preferred Shares was N/A to $8,222 in Q4 2011 from the same period last year, while for Dec 2011 it was $8,222, marking a year-over-year change of. This contributed to the annual value of $8,222 for FY2011, which is N/A change from last year.
  • Per Adma Biologics' latest filing, its Preferred Shares stood at $8,222 for Q4 2011.
  • Adma Biologics' Preferred Shares' 5-year high stood at $8,222 during Q4 2011, with a 5-year trough of $8,222 in Q4 2011.
  • Moreover, its 1-year median value for Preferred Shares was $8,222 (2011), whereas its average is $8,222.